Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

3D human skin models show promise for dermatology but face challenges in standardization and cost.

Poly-D,L-lactic acid boosts hair growth in aged skin by activating hair follicle stem cells.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

COVID-19 vaccines might cause hair loss, but JAK inhibitors can help regrow hair.

PRP is more effective than Minoxidil for treating alopecia areata.

3D-printed membranes with smart sensors can greatly improve tissue healing and have many medical applications.

Plant-based compounds can improve wound dressings and skin medication delivery.

Plant-derived exosomes show promise for healing skin wounds but need more research and trials.

CBD may help with skin and hair issues, but more research is needed.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

SVF may improve nanofat treatment for acne scars, but more research is needed.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Extracellular vesicles could revolutionize skincare by improving skin repair and anti-aging, but face regulatory and cost challenges.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

JAK inhibitors might help treat alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Janus membranes could greatly improve medical treatments like wound healing and bone regeneration.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Janus hydrogels improve medical adhesives by mimicking natural barriers for better tissue integration.